Stem Cell Therapy for Myocardial Infarction 2001–2013 Revisited

Stem Cell Reviews and Reports

Volumn 11, Issue 5, 2015, Pages 743-751

  Edlinger, Christoph ^a   Schreiber, Catharina ^a   Wernly, Bernhard ^a   Anker, Alexandra ^a   Ruzicka, Katja ^a   Jung, Christian ^b   Hoppe, Uta C ^a   Lichtenauer, Michael ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Basic research; Bibliometric; Clinical trials; Density equalizing maps; Myocardial infarction; Stem cells

Indexed keywords

ARTICLE; HEART INFARCTION; ISCHEMIC HEART DISEASE; JOURNAL IMPACT FACTOR; PARACRINE SIGNALING; PRIORITY JOURNAL; PUBLICATION; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; ANIMAL; BIBLIOMETRICS; BIOLOGICAL THERAPY; CYTOLOGY; HUMAN; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROCEDURES; STEM CELL;

ANIMALS; BIBLIOMETRICS; CELL- AND TISSUE-BASED THERAPY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84941182107     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-015-9602-z     Document Type: Article

References (43)

1. Velagaleti, R. S., Pencina, M. J., Murabito, J. M., Wang, T. J., Parikh, N. I., et al. (2008). Long-term trends in the incidence of heart failure after myocardial infarction. Circulation, 118, 2057–2062.
2. Penn, M. S., Francis, G. S., Ellis, S. G., Young, J. B., McCarthy, P. M., et al. (2002). Autologous cell transplantation for the treatment of damaged myocardium. Prog Cardiovasc Dis, 45, 21–32.
3. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.
4. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med, 355, 1210–1221.
5. Assmus, B., Honold, J., Schachinger, V., Britten, M. B., Fischer-Rasokat, U., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med, 355, 1222–1232.
6. Assmus, B., Schachinger, V., Teupe, C., Britten, M., Lehmann, R., et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation, 106, 3009–3017.
7. Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364, 141–148.
8. Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med, 355, 1199–1209.
9. Leri, A., & Anversa, P. (2013). Stem cells: bone-marrow-derived cells and heart failure--the debate goes on. Nat Rev Cardiol, 10, 372–373.
10. Meyer, G. P., Wollert, K. C., Lotz, J., Pirr, J., Rager, U., et al. (2009). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J, 30, 2978–2984.
11. Nowbar, A. N., Howard, J. P., Finegold, J. A., Asaria, P., & Francis, D. P. (2014). 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations. Int J Cardiol, 174, 293–298.
12. Schoffel, N., Vitzhum, K., Mache, S., Scutaru, C., Groneberg, D. A., et al. (2010). Critical analysis of publication procedures and evaluation regarding ankylosing spondylitis by density-equalizing mapping and scientometeric methods. Scand J Rheumatol, 39, 430–432.
13. Vitzthum, K., Mache, S., Quarcoo, D., Scutaru, C., Groneberg, D. A., et al. (2009). Scoliosis: density-equalizing mapping and scientometric analysis. Scoliosis, 4, 15.
14. Borger, J. A., Neye, N., Scutaru, C., Kreiter, C., Puk, C., et al. (2008). Models of asthma: density-equalizing mapping and output benchmarking. J Occup Med Toxicol, 3(Suppl 1), S7.
15. Addicks, J. P., Uibel, S., Jensen, A. M., Bundschuh, M., Klingelhoefer, D., et al. (2014). MRSA: a density-equalizing mapping analysis of the global research architecture. Int J Environ Res Public Health, 11, 10215–10225.
16. Fricke, R., Uibel, S., Klingelhoefer, D., & Groneberg, D. A. (2013). Influenza: a scientometric and density-equalizing analysis. BMC Infect Dis, 13, 454.
17. Gastner, M. T., & Newman, M. E. (2004). From the cover: diffusion-based method for producing density-equalizing maps. Proc Natl Acad Sci U S A, 101, 7499–7504.
18. Lovett, D. A., Poots, A. J., Clements, J. T., Green, S. A., Samarasundera, E., et al. (2014). Using geographical information systems and cartograms as a health service quality improvement tool. Spat Spatiotemporal Epidemiol, 10, 67–74.
19. Assmus, B., Leistner, D. M., Schachinger, V., Erbs, S., Elsasser, A., et al. (2014). Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. Eur Heart J, 35, 1275–1283.
20. Gyongyosi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., et al. (2015). Meta-analysis of cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res, 116, 1346–1360.
21. Seeger, F. H., Tonn, T., Krzossok, N., Zeiher, A. M., & Dimmeler, S. (2007). Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J, 28, 766–772.
22. Korf-Klingebiel, M., Kempf, T., Sauer, T., Brinkmann, E., Fischer, P., et al. (2008). Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J, 29, 2851–2858.
23. Jung, C., Fischer, N., Fritzenwanger, M., Thude, H., Ferrari, M., et al. (2009). Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age. Clin Res Cardiol, 98, 179–188.
24. Cohen, K. S., Cheng, S., Larson, M. G., Cupples, L. A., McCabe, E. L., et al. (2013). Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood, 121, e50–56.
25. du Pre, B. C., Doevendans, P. A., & van Laake, L. W. (2013). Stem cells for cardiac repair: an introduction. J Geriatr Cardiol, 10, 186–197.
26. Boyle, A. J., Schulman, S. P., Hare, J. M., & Oettgen, P. (2006). Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step. Circulation, 114, 339–352.
27. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med, 7, 430–436.
28. Lichtenauer, M., Mildner, M., Baumgartner, A., Hasun, M., Werba, G., et al. (2011). Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol, 106, 645–655.
29. Zeng, B., Ren, X., Lin, G., Zhu, C., Chen, H., et al. (2008). Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement. Cell Biol Int, 32, 1256–1264.
30. Kofidis, T., de Bruin, J. L., Yamane, T., Tanaka, M., Lebl, D. R., et al. (2005). Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation, 111, 2486–2493.
31. Barile, L., Lionetti, V., Cervio, E., Matteucci, M., Gherghiceanu, M., et al. (2014). Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res, 103, 530–541.
32. Ibrahim, A. G., Cheng, K., & Marban, E. (2014). Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports, 2, 606–619.
33. Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S., Choo, A., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res, 4, 214–222.
34. Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med, 11, 367–368.
35. Perez-Ilzarbe, M., Agbulut, O., Pelacho, B., Ciorba, C., San Jose-Eneriz, E., et al. (2008). Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail, 10, 1065–1072.
36. Dai, W., Hale, S. L., & Kloner, R. A. (2007). Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med, 2, 63–68.
37. Niagara, M. I., Haider, H., Jiang, S., & Ashraf, M. (2007). Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res, 100, 545–555.
38. Tang, Y. L., Zhao, Q., Qin, X., Shen, L., Cheng, L., et al. (2005). Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg, 80, 229–236. discussion 236–227.
39. Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res, 98, 1414–1421.
40. Lichtenauer, M., Mildner, M., Hoetzenecker, K., Zimmermann, M., Podesser, B. K., et al. (2011). Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol, 106, 1283–1297.
41. Vicencio, J. M., Yellon, D. M., Sivaraman, V., Das, D., Boi-Doku, C., et al. (2015). Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol, 65, 1525–1536.
42. Maltais, S., Tremblay, J. P., Perrault, L. P., & Ly, H. Q. (2010). The paracrine effect: pivotal mechanism in cell-based cardiac repair. J Cardiovasc Transl Res, 3, 652–662.
43. Pavo, N., Charwat, S., Nyolczas, N., Jakab, A., Murlasits, Z., et al. (2014). Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences. J Mol Cell Cardiol, 75C, 12–24.